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Summary
Sympathetic neurons depend on target-derived neurotrophic cues to control their survival and
growth. However, whether sympathetic innervation contributes reciprocally to the development of
target tissues is less clear. Here, we report that sympathetic innervation is necessary for the
formation of the pancreatic islets of Langerhans and for their functional maturation. Genetic or
pharmacological ablation of sympathetic innervation during development resulted in altered islet
architecture, reduced insulin secretion and impaired glucose tolerance in mice. Similar defects
were observed with pharmacological blockade of β-adrenergic signaling. Conversely, the
administration of a β-adrenergic agonist restored islet morphology and glucose tolerance in de-
innervated animals. Furthermore, in neuron-islet co-cultures, sympathetic neurons promoted islet
cell migration in a β-adrenergic dependent manner. This study reveals that islet architecture
requires extrinsic inductive cues from neighboring tissues such as sympathetic nerves, and
suggests that early perturbations in sympathetic innervation might underlie metabolic disorders.
Introduction
The sympathetic nervous system, a branch of the autonomic nervous system, is critical for
organ homeostasis. Postganglionic sympathetic neurons innervate a variety of peripheral
targets to regulate several physiological processes including blood glucose levels, cardiac
output and body temperature. During development, the survival and growth of sympathetic
neurons relies on diffusible cues released by their targets (Glebova and Ginty, 2005).
However, whether sympathetic innervation contributes reciprocally to the morphogenesis of
a target tissue remains unknown. The pancreas is a peripheral tissue that is richly innervated
by adrenergic sympathetic nerves originating from the celiac and superior mesenteric
ganglia (Woods and Porte, 1974). The islets of Langerhans in the endocrine pancreas
regulate blood glucose homeostasis, and islet dysfunction underlies diabetes mellitus. In
adult islets, sympathetic neural activity is well-known to inhibit insulin secretion and
promote glucagon release to elicit an increase in circulating glucose during stress and
exercise (Ahren, 2000; Woods and Porte, 1974). Developmentally, sympathetic innervation
of the pancreas is promoted by the target-derived neurotrophin, nerve growth factor, NGF.
Sympathetic innervation of the pancreas is incomplete in mice lacking NGF (Glebova and
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Ginty, 2004), while directed over-expression of NGF in β-cells results in hyper-innervation
of the pancreatic islets (Edwards R. H. et al., 1989). The onset of sympathetic innervation is
coincident with stages of rapid growth, differentiation and maturation in the embryonic
pancreas (Burris and Hebrok, 2007). Previous studies indicate that pancreatic development
is dependent on instructive signals derived from neighboring tissues including the
mesenchyme and blood vessels (Golosow and Grobstein, 1962; Lammert et al., 2001). There
is also growing evidence that dysfunction of the neuronal elements in the developing
pancreas might be an instigating factor in the pathogenesis of pancreatic diseases. An early
loss of sympathetic fibers and glial cells in the pancreas has been observed in diabetic
animal models (Mei et al., 2002; Persson-Sjogren et al., 2005; Winer et al., 2003). However,
whether sympathetic innervation contributes to pancreatic organogenesis remains unknown.
Pancreatic islets are highly organized functional micro-organs with defined size, shape, and
a distinctive arrangement of endocrine cells. Islet architecture has been postulated to
underlie effective inter-cellular coupling, synchronized insulin release, and paracrine
regulation by the islet micro-vasculature (Bonner-Weir, 1988; Halban, 2004; Santos et al.,
1991; Stagner and Samols, 1986; Valdeolmillos et al., 1989). Although inter-species
differences in islet organization have been reported (Cabrera et al., 2006; Wieczorek et al.,
1998), significant evidence suggests a unifying model that islet architecture, which
optimizes cell-cell interactions between β-cells, is essential in the acquisition of an adult
pattern of insulin secretion (Halban et al., 1982; Konstantinova et al., 2007; Ravier et al.,
2005; Yamagata et al., 2002). Perturbed islet organization is also a characteristic feature in
diabetic humans, and in animal models of the disease (Gepts and Lecompte, 1981; Gomez
Dumm et al., 1990; Kilimnik et al., 2011; Tokuyama et al., 1995). In murine models, islet
architecture has been shown to be established during late embryonic to early neonatal stages
through a sequence of morphogenetic events, including delamination of endocrine
precursors from a primordial ductal epithelium, endocrine cell migration into the
surrounding mesenchyme and clustering to form nascent islets (Puri and Hebrok, 2010).
While a cascade of transcription factors have been identified in the regulation of pancreatic
cell specification and growth, relatively little is known about the signals responsible for the
coordination of endocrine cell migration and establishment of islet organization.
By employing genetic and chemical ablation of sympathetic neurons in mice, we show that
sympathetic innervation is necessary for establishing pancreatic islet shape and
cytoarchitecture during development. Sympathectomized mice exhibit impaired glucose
tolerance due to defects in glucose-stimulated insulin secretion later in life. Using neuron-
islet co-cultures, we show that sympathetic neurons promote the directed migration of β-
cells. We identify the nerve-derived signal as norepinephrine acting via pancreatic β-
adrenergic receptors to influence islet cell migratory behavior. The effects of sympathetic
de-innervation on islet architecture and glucose tolerance are recapitulated by the
developmental blockade of β-adrenergic signaling. Remarkably, the pharmacological
stimulation of β-adrenergic signaling during development is sufficient to restore islet
morphologies and glucose metabolism in sympathectomized mice. Together, our results
indicate that sympathetic neurons use noradrenergic signaling to establish the architecture of
pancreatic islets, and that this inductive interaction at early stages of development is critical
for mature islet function in regulating glucose metabolism.
Results
Sympathetic innervation is necessary for establishing islet architecture
To address the role of sympathetic innervation in pancreatic islet development, we
visualized sympathetic nerves in the developing pancreas using immunofluorescent staining
for tyrosine hydroxylase (TH), a sympathetic nerve marker, on tissue sections from MIP-
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GFP transgenic mice, which express green fluorescent protein (GFP) reporter under the
insulin promoter (Hara et al., 2003). We found that sympathetic fibers innervate the
developing pancreas as early as embryonic day 14.5 (E14.5), when GFP-labeled β-cells are
scattered throughout the pancreas (Figure 1A). At E18.5, more GFP-labeled β-cells are
found in the vicinity of TH-positive sympathetic fibers, where they begin to form aggregates
(Figure 1B). By the first postnatal week (P6), discrete islet clusters are formed and wrapped
by sympathetic fibers (Figure 1C). Strikingly, ablation of sympathetic innervation in
neonatal mice using the neurotoxin, 6-hydroxydopamine (6-OHDA)(Kostrzewa and
Jacobowitz, 1974), resulted in a profound disorganization of islets, with the islets appearing
as large streak-like aggregates instead of the characteristic globular clusters (Figures 1D, E).
Daily administration of 6-OHDA in newborn mice resulted in complete loss of sympathetic
innervation by P6 (Supplemental Figures S1A and S1B).
We further used a genetic approach to ablate sympathetic innervation. The survival and
target innervation of sympathetic neurons depend on the expression of the TrkA receptor,
which mediates trophic effects of the neurotrophin, NGF, secreted by target tissues (Glebova
and Ginty, 2005). We crossed mice harboring a conditional (floxed) TrkA allele (Chen et al.,
2005) with mice expressing TH-driven Cre recombinase (TH-Cre) (Gong et al., 2007). In
TH-Cre;TrkAf/f mutant mice, we observed a selective depletion of TrkA protein in
sympathetic neurons, whereas the expression of TrkA in islets was unaffected (Figure 1F).
Previous studies have reported that in rodents, TrkA is be localized to β-cells in neonatal
and adult islets (Kanaka-Gantenbein et al., 1995; Miralles et al., 1998). By the first week of
birth (P6), while an enrichment of TH-positive sympathetic fibers was observed at the
periphery of islets in control TrkAf/f animals (Figure 1G, arrows) (Burris and Hebrok, 2007;
Rodriguez-Diaz et al., 2011), there was a complete loss of sympathetic innervation in the
pancreas and several other peripheral tissues in TH-Cre;TrkAf/f mutant mice (Figure 1H and
Supplemental Figures S1C–H).
In neonatal mice, immunostaining with the islet hormone markers, insulin and glucagon,
revealed that wild-type islets had coalesced into globular clusters with the stereotypical
arrangement of insulin-producing β-cells at the core surrounded by glucagon-producing α-
cells at the periphery or mantle (Figure 1I). In contrast, in TH-Cre ;TrkAf/f mutants,
significant disruptions in islet cytoarchitecture were evident with islets appearing as
disorganized aggregates with an intermingling of α-cells and β-cells within the islet core
(Figures 1J–L). The total numbers of α- and β-cells remained unaffected (Figure 1M).
Despite the perturbation of islet organization in TH-Cre;TrkAf/f mice, the islets still retained
a dense meshwork of micro-vasculature, indicating that ablation of innervation does not
impair islet vascularization (Figures 1N, O). Significant disruptions in islet cytoarchitecture
with mixed α-cells and β-cells within the islet core, in the absence of any significant
changes in islet cell numbers, were also observed in the neonatal 6-OHDA-injected mice
(Supplemental Figures S1I–M). These results suggest that sympathetic innervation is
necessary for the establishment of islet shape and cytoarchitecture.
TH is also expressed in a subset of β-cells in the wild-type pancreas (Teitelman and Lee,
1987). Consistent with previous reports (Teitelman and Lee, 1987), we found 3% of insulin-
positive β-cells showing TH immunoreactivity in wild-type islets (Supplemental Figures
S1N, arrowheads, and S1P). We noticed there was a large increase in the number of TH-
expressing β-cells in TH-Cre;TrkAf/f mice (Supplemental Figures S1O and S1P). Despite
the increase in TH expression in TH-Cre;TrkAf/f mutant islets, no changes in TrkA levels
were detected by immunoblotting (Figure 1F) or quantitative PCR analysis (Supplemental
Figure S1Q), indicating that the islet deficits observed in TH-Cre;TrkAf/f mice were not due
to changes in TrkA levels in the islets themselves. Interestingly, the number of TH-positive
β-cells were unaffected by 6-OHDA treatment (Supplemental Figures S1R–T).
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Sympathetic innervation is required for islet cell-cell contacts and glucose-stimulated
insulin secretion
Given that perturbations in cytoarchitecture are associated with alterations in cell-cell
interactions within islets (Jain and Lammert, 2009), we analyzed the expression of the major
islet cell adhesion molecules, Neural Cell Adhesion Molecule (N-CAM) and E-cadherin
(Dahl et al., 1996; Esni et al., 1999). In postnatal TH-Cre;TrkAf/f islets, we observed an
overall reduction in N-CAM expression in β-cells (Figures 2A, B), with little
immunoreactivity detected at the junctions between adjacent β-cells (Figures 2C, D).
Immunostaining analyses also revealed a down-regulation in E-cadherin levels in mutant β-
cells (Figures 2E, F). In mutant β-cells that still showed E-cadherin immunoreactivity, there
were noticeable changes in its sub-cellular distribution. While wild-type β-cells showed a
continuous distribution of E-cadherin at the sites of β-cell-cell contacts (Figure 2G), we
observed a “patchy” uneven pattern of E-cadherin labeling between neighboring β-cells in
mutant islets (Figure 2H). These analyses also revealed irregularly spaced clusters of β-cells
in mutant islets, with “lesions” that were devoid of any cells (arrowheads in Figures 2B and
2F), compared to control islets where β-cells were closely packed (Figures 2A and 2E).
Together, these results indicate that the loss of sympathetic innervation results in
abnormalities in cell-cell contacts and cellular spacing of β-cells in TH-Cre;TrkAf/f islets.
Islet morphology and cytoarchitecture have been postulated to be determinants in the
acquisition of functional maturity (Bosco et al., 1989; Halban et al., 1982; Hopcroft et al.,
1985; Ravier et al., 2005). We thus assessed glucose-stimulated insulin secretion (GSIS) in
TH-Cre;TrkAf/f mice and wild-type litter-mates at one month of age, when islets have
acquired functional maturity (Jermendy et al., 2011). Mutant islets exhibited significant
reduction in GSIS (Figure 2I), although they had normal insulin content (Figure 2J). The
attenuated response of de-innervated islets to a glucose challenge suggests that sympathetic
innervation during development is necessary for functional maturation of the islets. To
address the mechanisms underlying deficient GSIS in de-innervated islets, we assessed
aspects of glucose sensing and insulin trafficking. The β-cell-specific glucose transporter,
Glut2, is essential for glucose entry into β-cells and activation of the glycolytic pathway that
subsequently fuels insulin secretion (Thorens, 2003). Glut2 deletion leads to severe defects
in insulin secretion in mice (Guillam et al., 1997). Although it is reported that Glut2 is not
the predominantly expressed glucose transporter in human β-cells (De Vos et al., 1995), new
evidence points to recessive mutations in Glut2 in patients with neonatal diabetes (Sansbury
et al., 2012; Yoo et al., 2002). TH-Cre;TrkAf/f islets exhibited reduced protein expression
and surface localization of Glut2 at one month of age (Figures 2K–N), and these deficits
were evident as early as P6 (Supplemental Figures S2A–D). The mutant islets also failed to
secrete insulin in response to potassium chloride-mediated depolarization (Figure 2I),
suggesting defects in the mobilization of a readily releasable pool of insulin (Seino et al.,
2011). Ultrastructural analyses revealed fewer insulin granules at or very close (within 50
nm) to the plasma membrane in TH-Cre;TrkAf/f islets compared to control TrkAf/f islets
(Figures 2O–Q). The total numbers of insulin granules were not significantly different
between control and mutant β-cells (Figure 2R), consistent with the finding in Figure 2J.
Together, these results indicate that the failure of mutant islets to respond to glucose arises
from impaired glucose sensing and a reduction in the number of docked insulin granules.
We also noticed that TH-Cre;TrkAf/f animals exhibited reductions in islet size that were
only manifested by one month of age (Figure 2N and Supplemental Figures S2E–G). The
decreased islet mass in mutant animals is likely, at least in part, due to an overall reduction
in body weight in mature TH-Cre;TrkAf/f animals (Supplemental Figures S2H and S2I). The
exocrine, ductal and vascular compartments in TH-Cre;TrkAf/f pancreata all appeared
normal (data not shown).
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Sympathectomized mice are glucose intolerant
We then assessed metabolic parameters at the whole animal level in TH-Cre;TrkAf/f mice.
At one month of age, TH-Cre;TrkAf/f mice showed normal fasting blood glucose levels
(Supplemental Figure S3A), but were hyperglycemic when fed ad libitum (Figure 3A).
Further, when TH-Cre;TrkAf/f mice were challenged in a glucose tolerance test, they had
significantly elevated blood glucose levels as compared to control TrkAf/f mice (Figure 3B).
Consistent with reduced glucose-stimulated insulin secretion in isolated TH-Cre ;TrkAf/f
islets, plasma insulin levels were severely attenuated in response to the glucose challenge in
TH-Cre;TrkAf/f mice (Figure 3C). However, the TH-Cre;TrkAf/f mice responded normally
with a significant reduction in blood glucose levels when injected with insulin (Figure 3D),
suggesting that the insulin sensitivity of muscle, adipose and liver tissues is not perturbed
despite the loss of sympathetic innervation. In addition, the plasma levels of other pancreatic
hormones, glucagon and ghrelin, as well as that of several non-pancreatic hormones known
to influence β-cell biology, i.e., the gut-derived incretins (GIP and GLP-1), other gut-
derived peptides (cholecystokinin, gastrin, and secretin) as well as adipose-derived leptin
were all normal in TH-Cre;TrkAfl/fl mice (Supplemental Figures S3B–I). Together, these
findings indicate that sympathetic innervation during development is necessary for glucose
homeostasis later in life, and that the impaired glucose tolerance in the mutants arises
primarily from islet dysfunction rather than broader physiological defects stemming from
the loss of sympathetic innervation.
Sympathetic de-innervation in mature animals does not affect islet architecture and
glucose tolerance
To determine whether sympathetic innervation is required during later postnatal stages of
development for islet architecture and glucose responsiveness, we ablated sympathetic
innervation in young animals at postnatal day 21 by 6-OHDA injection, after the mature
organization of islets has been established. Examination of 6-OHDA treated animals at 1.5
months of age revealed depletion of sympathetic fibers in the pancreas (Figures 4A, B).
However, no defects were observed in islet architecture or in glucose tolerance of
sympathectomized mice (Figures 4B, C), indicating that sympathetic innervation is
dispensable for the maintenance of islet architecture and glucose tolerance.
Sympathetic neurons promote β-cell migration through norepinephrine signaling
How does sympathetic innervation influence islet formation during development? The
defects in islet architecture observed in TH-Cre;TrkAf/f mice (Figures 1E and J) were
reminiscent of the phenotypes reported in mice where endocrine cell migration had been
disrupted (Gannon et al., 2000; Kim et al., 2005; Miettinen et al., 2000). Endocrine
progenitor cells migrate away from the ducts to form mature islets. The degree of islet-duct
association is a well-established criterion of endocrine cell migratory behavior during
development (Miettinen et al., 2000). The close association of islets with ducts is a feature
commonly observed in neonatal mice compared to functionally mature animals. We found
that one month-old TH-Cre;TrkAf/f mice exhibited a significantly smaller ductal-islet
distance (Figure 5A–C), a hallmark of reduced endocrine cell migration. We established co-
cultures of sympathetic neurons with fluorescently labeled β-cells isolated from MIP-GFP
transgenic mice, and found that β-cells migrated toward explants of sympathetic ganglia
when co-cultured in a three dimensional Matrigel matrix, while β-cells cultured alone
exhibited little to no movement in the matrix over 7 days in culture (Figures 5D–G and
Supplemental Figures S4A and S4B). Consistent with migratory behavior, β-cells in close
proximity to sympathetic axons frequently exhibited polarized morphologies (Figures 5H, I).
The β-cell migratory behavior was specific to the presence of sympathetic neurons, because
little to no migration was observed in the presence of either non-neuronal COS cells or
sensory neurons from dorsal root ganglia (DRGs) (Figure 5J). A modified Sholl analysis
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(Figure 5K) to quantify the overall distribution of the β-cells over the culture period
revealed a gradual and directed movement of β-cells toward sympathetic explants (Figures
5L, M).
Sympathetic nerves innervating the pancreas release the neurotransmitter norepinephrine,
which activates α- and β-adrenergic receptors (Ahren, 2000). Norepinephrine has been
shown to influence the migration of peripheral cell types including hematopoietic stem cells
and pancreatic cancer cells (Guo et al., 2009; Katayama et al., 2006). In the co-cultures,
migration of β-cells towards sympathetic ganglia was significantly reduced by addition of
the β-adrenergic receptor antagonist propranolol (Figures 5N, 5J and Supplemental Figure
S4C). In contrast, the α-adrenergic antagonist phentolamine had no effect (Figure 5J and
Supplemental Figure S4D). None of the treatments changed the total number of cultured β-
cells (Supplemental Figure S4E). In addition, the effects of sympathetic ganglia were
specific to β-cells. The ganglia explants had no effect on migration or numbers of glucagon-
expressing α-cells in the co-cultures (Supplemental Figures S4F and S4G). These results
suggest a model in which sympathetic neurons regulate islet formation during development
by promoting β-cell migratory behavior through noradrenergic signaling.
Developmental β-adrenergic signaling regulates islet architecture and glucose metabolism
To test the hypothesis that sympathetic neurons use noradrenergic neurotransmission to
regulate islet structure and function, we examined the effects of developmental blockade of
β-adrenergic signaling on islet formation and functional maturation in vivo. We
administered propranolol daily to pregnant wild-type mice from E18, and continued
injections in the neonatal pups until P6. Propranolol injections did not affect islet
sympathetic innervation (Supplemental Figures S5A and S5B) but resulted in disruptions to
neonatal islet architecture (Figures 6A–D), which mimicked the phenotypes observed in TH-
Cre;TrkAf/f pups. Additionally, when propranolol-injected animals were assessed six weeks
after the treatment, they exhibited glucose intolerance and hyperglycemia in the fed state
(Figures 6E, F). These results provide evidence that β-adrenergic blockade during the
developmental window of E18 to P6 impairs glucose metabolism later in life.
Next, we asked whether adrenergic stimulation during development would be sufficient to
restore islet morphologies and functional maturity in the sympathectomized animals?
Treatment of TH-Cre;TrkAf/f mice with the β-adrenergic agonist, isoproterenol, from E18 to
P6 resulted in a significant improvement in islet architecture by P6, in the absence of
sympathetic innervation (Figures 6G–L and Supplemental Figure S5C and S5D). Since
sympathetic nerves are usually aligned with the pancreatic vasculature (Burris and Hebrok,
2007; Chiu et al., 2012), these results imply that, despite the absence of innervation in TH-
Cre;TrkAf/f mice, isoproterenol released from the islet vasculature may elicit directional
migration of endocrine cells, similar to the effects of norepinephrine released from nerve
terminals. Isoproterenol treatment during E18 to P6 also improved glucose tolerance and
significantly lowered fed blood glucose levels in TH-Cre;TrkAf/f mice, when these
metabolic parameters were examined 6 weeks later (Figures 6M, N). Sympathetic
innervation, islet architecture and glucose tolerance in control TrkAf/f animals were
unaffected by the isoproterenol administration during development (Figures 6H, K, L, M, N
and Supplemental Figure S5C). Together, the loss and gain-of function analyses indicate
that islet architecture and subsequent function relies on β-adrenergic signaling during
development.
Discussion
To date, all studies on sympathetic innervation of the pancreas have focused on the
modulatory functions in adult islets during stress and exercise (Ahren, 2000; Woods and
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Porte, 1974). Here, we provide the first evidence for sympathetic innervation in organizing
islet architecture during normal development. Further, we demonstrate that this inductive
interaction at early stages is critical for mature islet function in regulating glucose
metabolism. It is well-established that sympathetic innervation of the embryonic pancreas
occurs in response to target-derived NGF, which then supports survival of innervating
neurons (Glebova and Ginty, 2005). Our findings support the model that, during
development, sympathetic nerves, in turn, release norepinephrine that activates β-adrenergic
signaling in migrating β-cells to influence islet architecture and the acquisition of functional
maturity (Figure 7). Similar to TH-Cre;TrkAf/f animals,β-adrenergic receptor knockout mice
are glucose intolerant and have reduced insulin secretion due to perturbations in Glut2 levels
when analyzed at adult stages (Asensio et al., 2005; Santulli et al., 2012), although a detailed
analysis of islet development remains to be done in these mice. Together, these findings
highlight reciprocal signaling between sympathetic neurons and the pancreas that results in
the co-development of these two physiological systems.
We found that both chemical and genetic ablation of sympathetic innervation during
development resulted in similar alterations in islet shape and cellular organization. In
ablating sympathetic innervation, it would have been ideal to accomplish pancreas-selective
deletion of sympathetic fibers. However, a potential genetic approach of pancreas-specific
deletion of the sympathetic neuron survival factor, NGF, would be expected to perturb NGF
signaling within the pancreas and thus affect pancreas development. Moreover, surgical
lesioning of sympathetic projections to the pancreas cannot be accomplished in embryonic
or neonatal pups. Despite that our approaches for de-innervation were not pancreas-specific,
we provided multiple lines of evidence that indicate a direct action of sympathetic
innervation on islet architecture and function. First, in neuron-islet co-cultures, sympathetic
neurons directly promote β-cell migratory behavior in a manner dependent on noradrenergic
signaling. Second, isolated islets from sympathectomized mice show attenuated glucose-
stimulated insulin secretion in vitro, suggesting islet-intrinsic defects with de-innervation.
Third, when injected with insulin, sympathectomized mice responded normally with a
significant reduction in blood glucose levels, indicating normal insulin sensitivity in
peripheral tissues despite the loss of sympathetic innervation. Fourth, in TH-Cre;TrkAf/f
animals, we did not observe any changes in the plasma levels of several intestinal hormones
and leptin that are known to influence β-cell physiology. Finally, consistent with recent
findings showing that mutant mice lacking sympathetic innervation due to genetic deletion
of a key transcription factor, Phox2b, have normal vascular patterning of the heart (Nam et
al., 2013), we found that vascular organization was intact in TH-Cre;TrkAf/f islets. The
preservation of the vasculature further supports that the structural and functional deficits in
TH-Cre;TrkAf/f islets indeed arises from the loss of sympathetic nerves.
We did observe a difference between the genetic and chemical approaches of
sympathectomy. We found an increase in the number of TH-positive β-cells in TH-
Cre;TrkAf/f mice, but not in 6-OHDA-treated animals. An up-regulation in TH expression
has been reported in functionally immature or stressed islets (Teitelman et al., 1988;
Teitelman and Lee, 1987). The reasons for TH expression in β-cells, and the functional
consequences of increased TH-positive cells in TH-Cre;TrkAf/f islets remain unclear. To our
knowledge, there are no reports of β-cells synthesizing or releasing catecholamines, raising
the intriguing possibility of TH functions in the pancreatic cells that are independent of
catecholamine biosynthesis. It is also important to note that 6-OHDA is unlikely to have a
direct effect on islets since rodent β-cells, unlike human β-cells, lack the dopamine re-
uptake transporter used by 6-OHDA (Schafer et al., 2013).
Our findings imply a causal relationship between the early developmental perturbations in
islet architecture and the later functional deficits in sympathectomized animals. Both
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sympathectomy and β-adrenergic antagonism resulted in defects in islet architecture during
development and glucose intolerance later in life. Importantly, the restoration of islet
architecture, with β-adrenergic stimulation in sympathectomized animals, correlated with
improved function. In line with previous studies implicating islet architecture in
homogeneous and synchronous secretory responses, our results suggest that the disorganized
islet clusters in the TH-Cre;TrkAf/f mice with the peripheral α-cells interspersed among the
core β-cells compromises the homotypic inter-cellular interactions between β-cells that is
required for optimal insulin secretion (Halban et al., 1982; Konstantinova et al., 2007;
Smolen et al., 1993). Consistent with this notion, in de-innervated islets, we observed
abnormalities in the expression and localization of N-CAM and E-cadherin that are known
mediators of β-cell-cell contacts and function. Similar to our observations in TH-Cre;TrkAf/f
mice, N-CAM−/− mutant mice show abnormal islet architecture with intermingling of α- and
β-cells within the islet core as well as impaired glucose tolerance in vivo (Esni et al., 1999;
Olofsson et al., 2009). E-cadherin is necessary for β-cell clustering during pancreas
development and glucose-stimulated insulin secretion (Dahl et al., 1996; Jaques et al., 2008;
Yamagata et al., 2002). The relevance of inter-cellular contacts in normal β-cell function is
underscored by animal and human studies suggesting that perturbations in islet architecture,
due to injury or disease, are closely correlated with metabolic dysfunction (Gepts and
Lecompte, 1981; Gomez Dumm et al., 1990; Kilimnik et al., 2011; Tokuyama et al., 1995).
In addition, it is recognized that, in the current translational efforts for diabetes treatment,
preserving the three-dimensional arrangement of transplanted β-cells could contribute to the
long-term survival and optimal function of the transplants (Halban, 2004; Van Hoof et al.,
2011). It will be of interest, in future studies, to identify the signaling pathways and
transcriptional programs disrupted by loss of cell-cell contacts in the de-innervated islets.
The reduced Glut2 levels and defects in docked insulin granules in TH-Cre;TrkAf/f mice
suggest that the signaling pathways impinge on the glucose sensing and insulin trafficking
machinery.
Recent studies have reported that human and murine islets have distinct architecture, with
the different endocrine cell types being interspersed within human islets (Brissova et al.,
2005; Cabrera et al., 2006). These findings imply that, for human islet function, heterotypic
rather than homotypic cellular interactions within islets predominate. However, other
findings suggest that, like rodent models, human islets, also require β-cell-cell contacts for
efficient glucose-stimulated insulin secretion (Wojtusciszyn et al., 2008). In particular, at
higher glucose concentrations, homotypic contacts between human β-cells were better at
facilitating insulin secretion than heterotypic contacts (Wojtusciszyn et al., 2008), pointing
to a requirement for β-cell-cell interactions in potentiating insulin secretion especially under
high metabolic demand. Additionally, limited studies performed on human islets at
embryonic stages have reported that fetal islets are initially formed with a segregated
architecture typical of murine islets, compared to the mixed architecture seen in adult human
islets (Jeon et al., 2009; Piper et al., 2004). These findings imply a significant plasticity in
islet structure that may reflect the metabolic requirements at a particular stage.
Recent findings have also pointed to differences in the innervation patterns between mouse
and human islets (Rodriguez-Diaz et al., 2011). In human islets, sympathetic fibers do not
directly contact α- and β-cells as in murine islets, but instead innervate blood vessels within
the islets. Thus, in human islets, sympathetic nerve-mediated modulation of hormone release
is likely to be indirectly via release of norepinephrine into the islet circulation or by altering
the blood flow. However, in both mice and humans, neuronal activity has similar
physiological effects on inhibiting insulin and enhancing glucagon release in adult islets
despite the differences in innervation patterns and architecture (Ahren, 2000; Gilliam et al.,
2007; Taborsky, 2011). Thus, our study raises the possibility that during development,
sympathetic innervation and neuronal activity may have similar effects in mice and humans
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in coordinating islet organization and subsequent function. In support of this prediction, we
note that children with Congenital Insensitivity to Pain with Anhidrosis (CIPA), an inherited
neural disorder characterized by mutations in the TrkA gene, show a deficit in glucose
responsiveness (Schreiber et al., 2005), along with reduced peripheral innervation (Indo et
al., 1996), reminiscent of that seen in TH-Cre;TrkAf/f mice. It is now recognized that β-cell
dysfunction, inadequate insulin secretion and impaired glucose tolerance are early hallmarks
of type 2 diabetes (DeFronzo and Abdul-Ghani, 2011; Meece, 2007). Although autonomic
neuropathy is an established complication of diabetes (Kuehl and Stevens, 2012), it is
important to note that autonomic dysfunction in patients is already evident at the time of
diagnosis of diabetes or even during a clinically normal range of blood glucose levels
(Lehtinen et al., 1989; Pfeifer et al., 1984). Indeed, epidemiological studies suggest that
individuals with impaired autonomic functions are at greater risk for developing type 2
diabetes (Carnethon et al., 2003). Together with our findings, these studies suggest that
reduced or dysfunctional sympathetic innervation of the pancreas during development may
pose a risk factor for developing diabetes later in life.
Experimental Procedures
Mice
TrkAF592A (TrkAf/f) and TH-Cre mice were generous gifts from Dr. D. Ginty (JHMI) and
Dr. C. Gerfen (NIH), respectively. MIP-GFP mice were obtained from Jackson
Laboratories. All procedures relating to animal care and treatment conformed to institutional
and NIH guidelines.
Morphometric analyses of islets
10µm thick sections of pancreata were collected every 200µm and immunofluorescently
labeled for insulin and glucagon. For cell counting, 10–20 representative sections of P6
pancreata were chosen and imaged on a Zeiss AxioImager microscope using a 20×
objective. The number of α- and β-cells in islets were counted and divided by the number of
sections to determine endocrine cell numbers. Islet circularity was determined using the
ImageJ software (NIH) shape descriptors tool, calculated by the equation: circularity
index=4 ダ (area/perimeter2) with ‘1’ and ‘0’ denoting a perfect circle and an increasingly
elongated polygon, respectively. For cytoarchitecture analyses, an islet was considered to
have increased α-cell core localization if more than three α-cells were localized to greater
than two cell layers inside of the outer islet perimeter. For measurement of islet-ductal
distance, 25 islets in proximity to ducts were imaged per animal. ImageJ software was used
to measure the distance between the edge of the insulin-positive area and the closest
adjacent duct.
In vitro islet migration assays
Pancreata, superior cervical ganglia (SCGs), and dorsal root ganglia (DRGs) were harvested
from litters of 8–12 MIP-GFP mice on the day of birth. Pancreata were digested in 1mg/mL
collagenase (Type 2, Worthington Biochemical) solution in HBSS, washed with HBSS, and
islets picked under an inverted fluorescent microscope. Islets were then dissociated into
single cells by gentle trituration in 4mM EDTA in HBSS. Cell suspensions were
resuspended in DMEM with 10% fetal bovine serum and 5U/L penicillin/streptomycin,
Invitrogen. To plate the co-cultures, a 3µL drop of Matrigel (BD Biosciences) was placed in
the center of a collagen coated well in a 4-well culture dish (Thermo Scientific). One SCG
or DRG explant was embedded in this drop. The MIP-GFP islet cell suspension was then
diluted 1:1 with Matrigel, and 10µL of this cell suspension was plated around the central
drop containing the ganglia. Culture media containing 100ng/mL NGF was added and the
cultures maintained for 7 days at 37°C under 10% CO2, with fresh media added every other
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day. For experiments with COS cells, a dense suspension of COS cells was mixed 1:1 with
Matrigel, and plated in the center of the culture dish. In experiments using adrenergic
antagonists, after plating, cultures were allowed to recover overnight in culture media
containing NGF alone. The next day, fresh media containing NGF and 10µM of propranolol
(Sigma) or phentolamine (Sigma) was added. Cultures were plated in duplicates or
triplicates for each condition.
The cultures were imaged each day with day 1 being the day after plating, using a Zeiss
Axiovert microscope and a 2.5× objective. Four images were taken of each well and the
images stitched together using Adobe Photoshop. Sholl analyses were performed using
ImageJ software and the Sholl analysis plugin (Ghosh Lab). To perform the analysis, a
complete image of the culture was first subjected to a threshold to only include the GFP+
cells using the same settings for each image. The analysis plugin was then centered on the
location of the ganglia, and the following plugin parameters used: starting radius, 10µm;
ending radius, 5000µm; radius step size, 10µm; radius span, 1µm; span type, median. The
Sholl analysis plots for each well were obtained and the plots of replicate samples averaged
together.
To analyze the percentage of α- and β-cells that migrated to the center of the cultures at the
end of the experiment, the cultures were fixed in 4% PFA and immunostained with anti-
glucagon, anti-GFP or anti-β-III tubulin. After imaging, a 1mm diameter circle was
inscribed in the middle of the image centering on the ganglia and the number of GFP+ or
glucagon+ cells within this circle was compared to the total number of endocrine cells using
ImageJ software.
Electron microscopy
Pancreata from one month old control and mutant animals were minced and fixed in buffer
containing 3% formaldehyde, 1.5% glutaraldehyde, 5mM CaCl2, 2.5% sucrose, and 0.1M
sodium cacodylate for 1hr at room temperature. The tissue was post-fixed in 1% Palade’s
OsO4 for 1hr on ice, followed by incubation in Kellenberger’s uranyl acetate overnight at
room temperature. After dehydration through graded alcohols, the tissue was embedded in
Epon and ultra-thin (~90nm) sections were collected onto EM grids. These grids were then
imaged using an FEI Tecnai-12 TWIN transmission electron microscope operating at
100kV. Three islets were chosen at random per animal and three representative images of β-
cells within each islet were taken. For each image, the insulin granule density (granules/µm2
of cytoplasm) and number of granules within 50nm of the plasma membrane were
determined using ImageJ software.
Animal studies
Glucose tolerance and in vivo analysis of glucose-stimulated insulin
secretion and insulin sensitivity—For glucose tolerance tests, 1–1.5 month old mice
were fasted overnight, with a blood glucose reading the evening before the assay serving as
a fed blood glucose measurement. The next morning, mice were injected i.p. with 2g/kg
glucose (Sigma) dissolved in water, and blood glucose measurements made from tail blood
using a OneTouch Ultra glucometer at the indicated times (Gu et al., 2010). For in vivo
insulin secretion assays, 1–2 month old mice were fasted overnight before being injected i.p.
with 3g/kg of glucose. Blood was collected from the tail at the times indicated, spun down,
and the resulting plasma fraction subjected to insulin ELISA (Crystal Chem). For insulin
sensitivity tests, 1–2 month old mice were separated into individual cages with food the
evening prior to the assay. The next morning, mice were treated with 0.75U/kg of insulin
(Novolin-R, NovoNordisk) and blood glucose measurements made from tail blood at the
indicated times (Bruning et al., 1997).
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Analysis of glucose stimulated insulin secretion and total islet insulin content
in isolated islets—Islets were isolated as previously described (Wollheim et al., 1990).
Briefly, following euthanasia of mice, pancreata were distended using a 0.375mg/mL
collagenase solution (Collagenase P, Roche), dissolved in Hanks Buffered Salt Solution
(HBSS, Mediatech) and digested at 37°C. The digested pancreata were then washed with
HBSS and subjected to discontinuous density gradient centrifugation using different Ficoll
densities (Mediatech). The islet layers were collected, washed with HBSS, and islets hand-
picked under an inverted microscope for subsequent analyses. For total insulin content
assays, islets were immediately lysed in acid ethanol solution, and the amount of insulin
determined by ELISA. Insulin values were normalized to islet DNA content from the same
lysates using a Picogreen kit (Invitrogen).
For insulin secretion assays in isolated islets, harvested islets were allowed to recover
overnight in RPMI-1640 media containing 10% fetal bovine serum and 5U/L penicillin/
streptomycin (Invitrogen). Assays were performed in Krebs-Ringer HEPES buffer (KRBH)
containing low (2.8mM) glucose, high (25mM) glucose, or 30mM potassium chloride
(Sigma). Islets were washed in low glucose KRBH before being pre-incubated for 1hr in low
glucose KRBH. After pre-incubation, groups of 10 islets were hand picked into a 24 well
plate and allowed to incubate in the conditions indicated for 1hr. After incubation the
supernatant fraction was removed and the islets were lysed in acid ethanol, followed by
ELISA to determine the insulin concentration in both supernatant and islet fractions.
Measurement of plasma glucagon, ghrelin and non-pancreatic hormones—
Tail vein blood was collected from 1–1.5 month old mice in the evening prior to an
overnight fast (fed ad lib sample). After fasting, a second blood sample was collected (fasted
sample). Blood collected in capillary tubes was transferred to tubes containing a protease
inhibitor cocktail (Roche) on ice. Samples were spun down, and the plasma fraction
acidified to 0.05M HCl. Plasma samples were then subjected to a panel of ELISA assays,
following the respective manufacturers instructions: Glucagon, GLP-1, Cholecystokinin,
Secretin (Phoenix Pharmaceuticals), Gastrin-1 (RayBiotech), GIP (total, Millipore), Ghrelin
(active, Millipore), Leptin (Crystal Chem).
6-OHDA treatment—Beginning at day of birth (P0), TrkAf/f mice were injected
intraperitoneally (i.p) once daily with 250mg/kg of 6-OHDA (Sigma) freshly dissolved in
0.1% ascorbic acid (Sigma) in 0.9% saline (Sigma), or with ascorbic acid-saline solution as
a control. Pups were sacrificed at P6 and pancreata processed for TH, insulin and glucagon
immunofluorescence. For late postnatal treatments, mice were injected beginning at
postnatal day 21(P21) twice a week for 2 weeks. At 1.5 months of age, mice were subjected
to glucose tolerance measurements, and sacrificed to process their pancreata for
immunofluorescence.
Propranolol injections—Beginning at embryonic day 18 (E18), pregnant TrkAf/f mice
were injected i.p. daily with 20mg/kg of propranolol freshly dissolved in saline, or saline
alone as a control. After birth, pups were injected using the same dosing scheme until P6
when they were sacrificed and pancreata processed for TH, insulin and glucagon
immunofluorescence. In parallel experiments, animals injected with propranolol or saline
during E18 to P6 were allowed to recover for 6 weeks and glucose tolerance tests and blood
glucose levels assessed at 1.5 months of age.
Isoproterenol injections—Beginning at E18, pregnant TH-Cre;TrkAf/f and control
TrkAf/f and mice were injected daily with 30mg/kg of isoproterenol (Sigma) freshly
dissolved in saline, or saline alone as a control. After birth, pups were injected until P6 when
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they were sacrificed and pancreata processed for immunofluorescence. Isoproterenol- and
saline-injected animals were also allowed to grow to adulthood (1.5 months) for glucose
metabolism tests.
Statistical Analyses
All graphs and statistical analyses were done using GraphPad Prism software. Unless
otherwise noted in the figure legends, statistical significance was determined using an
unpaired, two-tailed Student’s t test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Sympathetic innervation during development is necessary for islet architecture
• Sympathectomized mice exhibit defects in insulin secretion and glucose
tolerance
• Sympathetic neurons promote endocrine cell migration via β-adrenergic
signaling
• Developmental β-adrenergic signaling regulates islet shape and glucose
metabolism
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Figure 1. Sympathetic innervation establishes islet architecture and the spatial distribution of
endocrine cells
(A–C) TH immunohistochemistry and GFP fluorescence reveals the organization of β-cells
into discrete clusters near sympathetic fibers during development in MIP-GFP mice. (D,E)
Chemical sympathectomy with 6-OHDA administration disrupts islet clustering in neonatal
MIP-GFP mice. GFP-positive β-cells (green) and DAPI (nuclei) staining are shown. (F)
Genetic ablation of sympathetic innervation in TH-Cre;TrkAf/f mice. Immunoblotting shows
depleted TrkA protein levels in superior cervical ganglia (SCGs) from TH-Cre;TrkAf/f mice
at postnatal day 2 (P2), and intact TrkA expression in islets. The p85 subunit of
phosphatidylinositol-3-kinase (PI-3K) was used to normalize for protein amounts. (G,H)
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Immunohistochemistry for TH and insulin shows that sympathetic axons (arrows)
surrounding control TrkAf/f islets (G) are lost in TH-Cre;TrkAf/f islets (H) by postnatal day
6 (P6). (I,J) Immunostaining for islet hormones shows disrupted arrangement of endocrine
cells within islets in neonatal (P6) TH-Cre;TrkAf/f mice. (K) Islet shape is quantified by
circularity index. (L) Percentage of islets with mis-localized α-cells. (M) Normal endocrine
cell numbers in P6 TH-Cre;TrkAf/f mutants. For all quantifications, n = 3 mice per
genotype; mean ± SEM; *p < 0.05, ***p < 0.001, t test. (N,O) Intact islet vasculature in
sympathectomized animals. The density and morphology of the pancreatic blood vessels
(arrows) and islet capillaries (arrowheads) are not compromised, despite the alterations in
islet architecture in TH-Cre;TrkAf/f pups. Blood vessels were fluorescently painted by
perfusing Alexa-633-conjugated wheat germ agglutinin (WGA) into TH-Cre;TrkAf/f and
control mice at P6. Scale bars, 50µm.
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Figure 2. Defects in islet cell-cell contacts and glucose-stimulated insulin secretion in
sympathectomized mice
(A, B) Reduced N-CAM expression in islets from postnatal (P21) TH-Cre;TrkAf/f mice
(P21). (C, D) Higher magnification images of regions from (A, B). (E, F) Reduced
expression of E-cadherin in islets from P21 TH-Cre;TrkAf/f animals compared to control
mice. (G, H) Higher magnification images of regions in (E, F) show an uneven distribution
of E-cadherin at junctions between adjacent β-cells in mutant islets. Mutant islets also
exhibit abnormalities in cellular spacing and gaps devoid of any cells (arrowheads in B and
F). Scale bars 50µm for (A, B, E, F) and 10 µm for (C, D, G, H). (I) Isolated islets from one
month-old TH-Cre;TrkAf/f mice secrete less insulin when challenged with high glucose or
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with potassium chloride treatment. Insulin released is expressed as a percentage of the total
insulin content. n = 5 mice per genotype; mean ± SEM; *p<0.05, t test. (J) Total insulin
content is normal in isolated islets from TH-Cre ;TrkAf/f mice. Insulin content is normalized
to total islet DNA content. n=4 mice per genotype; mean ± SEM. (K–N) Reduced
expression and surface localization of the glucose transporter, Glut2, in mutant β-cells as
revealed by immunostaining and immunoblotting. n=3 mice per genotype; mean ± SEM;
*p<0.05, t test. (O–Q) Ultrastructural analysis of β-cells reveals fewer insulin granules
within 50nm of the plasma membrane (arrowheads), in mutant islets. Numbers in (Q)
represent insulin granules docked per µm of the plasma membrane n=3 mice per genotype,
mean ± SEM; **p < 0.01, t test. (R) The total number of insulin granules (per µm2) are not
different between mutant and control islets. n=3 mice per genotype, mean ± SEM; t test.
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Figure 3. Sympathectomized mice exhibit impaired glucose tolerance but normal insulin
sensitivity
(A) Elevated blood glucose levels in one month-old TH-Cre;TrkAf/f compared to control
mice when fed ad libitum. n=9 mice per genotype; mean ± SEM; *p < 0.05, t test. (B)
Glucose intolerance in TH-Cre;TrkAf/f mice. Mice, at one month of age, were fasted
overnight, then injected i.p with a bolus of 2g/kg glucose at t=0. Blood glucose
measurements were made from tail vein at the indicated time intervals after glucose
injection. n=10 mice per genotype; mean ± SEM; *p < 0.05, **p < 0.01, t test. (C) Reduced
plasma insulin levels in response to a glucose injection (3g/kg glucose in TH-Cre;TrkAf/f
mice compared to control mice. n=8 control, 10 mutant mice, mean ± SEM; *p<0.05,
***p<0.001, t test. (D) Normal insulin sensitivity in TH-Cre;TrkAf/f mice. A significant
decrease (p<0.001, t test) in blood glucose levels was seen in both TH-Cre;TrkAf/f and
control mice at 30 minutes after insulin injection compared to t=0). Mice were treated with
0.75U/kg of insulin, and blood glucose measurements made from tail blood at the indicated
times post-injection. n=5 mice per genotype, t test, mean ± SEM,
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Figure 4. Sympathetic de-innervation in mature animals does not affect islet architecture and
glucose tolerance
(A–C) Normal islet morphology and glucose tolerance with 6-OHDA administration at a
late postnatal stage (postnatal day 21). P21-old mice were serially injected with 6-OHDA or
vehicle for 7 days, and then analyzed at 1.5 months of age. TH-positive sympathetic fibers
(arrows in A) are sparser in mature animals, and are completely lost with 6-OHDA
administration (B). n=6 mice for each treatment; t test, mean ± SEM.
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Figure 5. Sympathetic neurons promote β-cell migratory behavior through norepinephrine
signaling
(A–C) Ductal proximity of islets in one-month old TH-Cre;TrkAf/f mice. n=4 control and 3
mutant animals; mean ± SEM; *p < 0.05, t test. (D,E) Isolated β-cells exhibit directed
migration towards sympathetic (SCG) tissue explants plated in the center of a Matrigel
culture dish. Scale bars, 200µm. (F,G) Higher magnification images of the insets shown in
D,E. Scale bars, 50 µm. (H,I) β-cells align along sympathetic axons and adopt polarized
morphologies when cultured with neurons (arrows, I). Scale bars, 50 µm. (J) Percentage of
β-cells that have migrated toward the center of Matrigel cultures containing COS cell
aggregates, DRG or SCG explants with or without adrenergic antagonists after 7 days. n= at
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least 3 independent experiments; mean ± SEM; **p < 0.01, ***p < 0.001 by one-way
ANOVA and Tukey’s post-hoc test. (K–M) Sholl analysis to quantify the distribution of
GFP+ β-cells over 7 days in culture. The distribution of β-cells cultured alone does not
change significantly over 7 days (L), while there is a gradual shift in the distribution of β-
cells towards the center of the culture containing SCGs (M, arrow). Averaged profiles of
four independent experiments are plotted. (N) β-cells exhibit decreased migration towards
sympathetic explants in the presence of the β-adrenergic antagonist, propranolol (see J for
quantification).
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Figure 6. β-adrenergic signaling is necessary during development to regulate islet architecture
and glucose metabolism
(A,B) In vivo administration of propranolol (20 mg/kg body weight) during development
(E18-P6) results in defects in islet architecture in neonatal (P6) mice, compared to saline-
injected controls. (C,D) Quantification of islet shape and endocrine cell
compartmentalization in mice injected with saline or propranolol. n=5 animals per genotype;
mean ± SEM; **p < 0.01, ***p < 0.001, t test. (E) Glucose intolerance in one month-old
animals injected with propranolol during development (E18.5-P6), compared to vehicle-
treated controls. n=7,9 mice for vehicle and propranolol respectively;, mean ± SEM; *p <
0.05, t test. (F) Developmental administration of propranolol results in elevated fed blood
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glucose levels in mature animals at one month. n=7,9 mice for vehicle and propranolol
respectively; mean ± SEM; **p < 0.01, t test. (G–L) Restoration of islet morphologies in
neonatal TH-Cre;TrkAf/f mice treated with a β-adrenergic receptor agonist, isoproterenol,
from E18-P6. Isoproterenol administration (Iso, 30 mg/kg body weight) has no effect on
islet architecture in control TrkAf/f mice (G,H), but normalizes islet structure and
cytoarchitecture in TH-Cre;TrkAf/f mice (J) compared to saline-injected TH-Cre;TrkAf/f
mice (I). (K,L) Quantification of islet shape and endocrine cell compartmentalization in TH-
Cre;TrkAf/f and control mice injected with saline or isoproterenol. n = 3 mice for all
treatments except for TH-Cre;TrkAf/f + Iso where n=4 mice; mean ± SEM; *p < 0.05,
**p<0.01 one-way ANOVA with Tukey’s post-hoc test. (M) Developmental administration
of isoproterenol administration (E18-P6) rescues the glucose intolerance in one-month old
TH-Cre;TrkAf/f mice, compared to vehicle-injected TH-Cre;TrkAf/f mice. Isoproterenol had
no effect on glucose metabolism in control TrkAf/f mice. n=5 mice for vehicle- and Iso-
injections in TrkAf/f mice; n=6 for vehicle-injected TH-Cre;TrkAf/f mice and n=7 for Iso-
injected TH-Cre;TrkAf/f mice; mean ± SEM; *p < 0.05, **p<0.01 as determined by one-way
ANOVA and Tukey’s post-hoc test. (N) Normalization of fed blood glucose levels in in one-
month old TH-Cre;TrkAf/f mice treated with isoproterenol between E18-P6, compared to
saline-treated TH-Cre;TrkAf/f mice. n=5 mice for vehicle- and Iso-injections in TrkAf/f
mice; n=6 for vehicle-injected TH-Cre;TrkAf/f mice and n=7 for Iso-injected TH-
Cre;TrkAf/f mice; mean ± SEM; *p < 0.05, ***p<0.001 one-way ANOVA with Tukey’s
post-hoc test.
Borden et al. Page 27













Figure 7. Developmental interactions between sympathetic neurons and pancreatic endocrine
cells
Sympathetic innervation of the embryonic pancreas occurs in response to target-derived
NGF, which then supports survival of innervating neurons (Glebova and Ginty, 2005).
Sympathetic nerves release norepinephrine, which acts through β-adrenergic receptors on β-
cells to contribute to endocrine cell migration and formation of discrete islet clusters. Nerve-
dependent establishment of islet architecture is essential for intercellular contacts within
islets, β-cell maturation (i.e. Glut2 levels) and optimal glucose-stimulated insulin secretion.
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